and this Q should be about +$2million with less expense ratio. Last Q only had 4 wks of initial sales. Catch up and see the silver lining. Also low O/S and no typical OTC relentless dilution. not to mention the aforementioned PR about "big box" and other items that are now front and center as proof of concept has been acheived.